| Previous Close | 0.1850 |
| Open | 0.1800 |
| Bid | 0.1800 x N/A |
| Ask | 0.2000 x N/A |
| Day's Range | 0.1800 - 0.1900 |
| 52 Week Range | 0.1800 - 0.2400 |
| Volume | 10,000 |
| Avg. Volume | 37,064 |
| Market Cap | 31M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0150 |
| Earnings Date | Nov 29, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Terrace Global Inc. ("Terrace Global" or the "Company") (TSXV:TRCE), a multi-country operator focused on the development and acquisitions of international cannabis assets, believes it is well-positioned to capitalize on this week’s announcement, by Brazil’s National Agency for Health Surveillance ("Anvisa"), approving the importation and sale of medical cannabis while, at the same time prohibiting domestic cultivation.